Rankings
▼
Calendar
PASG FY 2024 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena
PASG
Passage Bio, Inc.
$29M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$70M
Net Income
-$65M
EPS (Diluted)
$-21.44
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$48M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$102M
Total Liabilities
$41M
Stockholders' Equity
$61M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$4M
+100.0%
Operating Income
-$70M
-$100M
+29.7%
Net Income
-$65M
-$102M
+36.5%
← Q4 2023
All Quarters
Q1 2024 →